ILMN has been granted a new patent
Mar 05, 2025, 11:33 PM
-10.84%
What does ILMN do
Illumina, headquartered in San Diego, develops life science tools for genetic analysis, employing 10,590 staff since its IPO in 2000. Its products span various applications, including oncology and agriculture.
ILMN filed a patent for "blocker methods" on Mon, March 25, 2024.
📡️ Health Care
Patents
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.